Business & regional news

First procedure performed at Axia Women’s Health by Dr. Vincent R. Lucente

Heart Rhythm 2026: Real-world outcomes reinforce Aurora EV-ICD system as a reliable option for indicated patients requiring protection from dangerously fast heart rhythms

Post-approval study’s primary cohort shows 70.2% target lesion primary patency consistent with pivotal randomized controlled trial results in a challenging population¹

Company honored for creating the world's first Adaptive deep brain stimulation (aDBS) system for people with Parkinson's

EMBRACE trial to study renal denervation with the Symplicity Spyral™ system and percutaneous coronary intervention (PCI) in the same procedure In SPYRAL HTN ON and OFF MED trials, patients...

Empowering endoscopists with meaningful insights

Milestone expands patient access to the first and most studied renal denervation therapy for hypertension.

Infuse™ is the only PMA-approved growth factor bone graft indicated for ALIF, OLIF, and TLIF

University of Colorado selected as a strategic academic partner given the strength of the capabilities to advance disruptive innovation in health care

Pharmacy Benefit agreements expand portfolio coverage to simplify access for eligible customers and providers

Results from Australia, Japan and Hong Kong highlight the potential impact across healthcare systems in the Asia-Pacific region

Onyx™ 18, 34 Liquid Embolic System offers step forward in treatment options for cSDH

Medtronic also announced completion of enrollment in SPYRAL AFFIRM, which aims to build robust real-world evidence across traditionally underserved patient populations

Avalus Ultra valve expands Medtronic Cardiac Surgery’s portfolio of
cardiac surgical innovations

Findings highlight the potential of new investigational waveforms for the all-in-one mapping and dual-energy ablation system in advancing treatment for ventricular arrhythmia patients

Backed by exceptional clinical outcomes, the Neuroguard IEP™ System’s unique 3-in-1 design provides enhanced embolic protection when it matters most.1-5, † Medtronic, a global leader in...

Dr. Arthur brings more than 20 years of experience as a practicing neurosurgeon and a commitment to innovation, patient safety, and improving stroke care outcomes

London office expansion underlines Medtronic’s commitment to fostering cross-industry collaboration, contributing to ambitions of the NHS 10-Year Health Plan and driving surgical innovation.

The pivotal Medtronic Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease (ADAPT-PD) trial demonstrates global clinical effectiveness, long-term safety, and patient preference

Japan is now the 77th country to receive regulatory approval for the Symplicity Spyral Renal Denervation System

Albany Medical Center performs first patient procedure in clinical trial for use of peripheral vasculature liquid embolization for active arterial hemorrhage

Medtronic advances pipeline with update on multi-organ denervation study and additional data recently presented at EuroPCR 2025

Large, international registry designed to expand real-world data for Symplicity blood pressure procedure for uncontrolled hypertension

Medtronic, a global leader in healthcare technology, is proud to announce that it has been honored with the 2025 MedTech Breakthrough Award for 'Best Overall Medical Device Solution' for its...

Medtronic, a global leader in healthcare technology, announced today that it has received CE (Conformité Européenne) Mark approval for several expanded indications for the treatment of coronary...

With its advanced multi-beat hemodynamic algorithm, the Argos™ monitor expands the parameters in the Medtronic perioperative portfolio

New investigational energy waveforms created specifically to target ventricular arrhythmias

Ventricular arrhythmia research will provide important clinical evidence using a new technology for patient population in need of new treatment options

Data from the largest study comparing drug-coated balloons presented as a late-breaking clinical trial at Cardiovascular Research Technologies 2025

The company will present clinical evidence at ATTD exploring challenges faced by women living with type 1 diabetes, from menstruation to pregestational diabetes

Taking the patient experience to the next stage

St. Francis Hospital in New York performs the first patient procedure in clinical trial for coronary artery disease

Study shows 67% mean reduction in Low-back Visual Analog Scale (VAS) pain score at 12 months; 87% of subjects had meaningful improvements in three or more quality of life (QoL) domains

Data to be presented at the North American Neuromodulation Society (NANS) Annual Meeting 2025; In all, Medtronic to highlight 22 poster and oral scientific data presentations

Data include durability of PulseSelect integrated with the Affera system, same day discharge and zero fluoroscopy with Affera and Sphere-9™ Catheter

Highlights underscore positive momentum of commercial launch of Affera in the U.S. and continued strong adoption of PulseSelect globally

Real-world use continues to demonstrate safety, efficacy and efficiency of both PFA technologies amid global expansion

Agreement includes option to acquire the company

Harmony™ Transcatheter Pulmonary Valve system approval expands minimally invasive treatment options for patients with congenital heart disease across European Union

Two data releases at London Valves 2024 build on Evolut’s legacy of valve design and performance: Optimize PRO study demonstrates improved procedure efficiencies and valve performance Pooled...

New data from Australia, Japan, India, Singapore, Hong Kong, and South Korea demonstrates the MiniMed™ 780G is driving consistent clinical outcomes in diabetes management.